Tower Research Capital LLC TRC Buys New Position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)
Tower Research Capital LLC TRC purchased a new stake in Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 6,433 shares of the company’s stock, valued at approximately $86,000. Other institutional investors and hedge funds […]
